Evidence map›Paper›PMID 40837569›Full record

ArticleFrontiers in medicine2025

Clinical performance of an interactive platform based on artificial intelligence in ophthalmology: experience in a third-level reference center.

Felix Armadá-Maresca, María Capote-Díaz, María Del Pino Cidad-Betegón, Rosa María Cordero-Ros, Lilian Martínez-Godoy, Paola Vázquez-Colomo, Beatriz Laín-Olia, Bruno Songel-Sanchís, Alfonso Caminos-Melguizo, Inas Baoud-Ould-Haddi

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Felix Armadá-MarescaOphthalmology Department, Hospital Universitario La Paz, Madrid, Spain.
María Capote-DíazOphthalmology Department, Hospital Universitario La Paz, Madrid, Spain.
María Del Pino Cidad-BetegónOphthalmology Department, Hospital Universitario La Paz, Madrid, Spain.
Rosa María Cordero-RosOphthalmology Department, Hospital Universitario La Paz, Madrid, Spain.
Lilian Martínez-GodoyOphthalmology Department, Hospital Universitario La Paz, Madrid, Spain.
Paola Vázquez-ColomoOphthalmology Department, Hospital Universitario La Paz, Madrid, Spain.
Beatriz Laín-OliaZink Medical, Health Market Consulting, Ltd., Valencia, Spain.
Bruno Songel-SanchísZink Medical, Health Market Consulting, Ltd., Valencia, Spain.
Alfonso Caminos-MelguizoZink Medical, Health Market Consulting, Ltd., Valencia, Spain.
Inas Baoud-Ould-HaddiZink Medical, Health Market Consulting, Ltd., Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To assess the diagnostic performance of an interactive platform for ophthalmology in a real-world clinical setting at a tertiary care center. Methods: A prospective, observational, cross-sectional study was conducted on consecutive patients referred by general practitioners to the Ophthalmology Department of a third-level University Hospital. Participants underwent automated ocular evaluation using DORIA ( Results: Of 2,774 referred patients, 2,478 (89.3%) attended their appointments and were examined. Among them, the mean age was 58.5 ± 14.5 years and 1,535 (61.9%) were women. Visual acuity loss with 591 (24.2%) patients and fundus examination 421 (17.3%) patients were the most common referral reasons. Based on DORIA results, ophthalmologists concluded that 807 patients (32.6%) required no further ophthalmological care, 858 (34.6%) needed follow-up with a general ophthalmologist, and 341 (13.8%) were referred to primary care. In a detailed assessment of 2,478 cases, 1,148 (46.3%) were discharged or referred to primary care, while 472 (35.5%) individuals required specialized ophthalmology care. Conclusion: The platform might be considered as a valuable solution to the waiting list issue, reducing specialist interventions, and optimizing healthcare resources. Real-world findings suggest potential cost savings and improved patient management. Further studies are necessary to validate its comparative effectiveness.

Indexed as

artificial intelligencediagnostic performanceinteractive platformophthalmologyscreening

Identifiers

PMID40837569
PMCPMC12364005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.